PILOTS

PILOT 1

Cardiovascular Affordability Accelerator. Why first: cardiovascular disease remains the leading cause of death globally, and this area offers practical, measurable affordability gains within 36 months.

PILOT 2

Diabetes Continuity and Insulin Access Pathway. Focus: lower treatment interruption through practical cost-reduction and access partnerships.

PILOT 3

Secondary Prevention Polypill Access Pilot. Focus: simplify long-term therapy after heart attack or stroke and reduce cost-related drop-off.

SIMPLE TIMELINE

  1. Months 1–6: Partner recruitment and target selection.
  2. Months 7–18: Pilot structuring and launch
  3. Months 19–30: Expansion and evidence generation.
  4. Months 31–36: Evaluation, replication planning, and biologics-readiness transition.

JOIN US IN BRINGING HEALTH CARE AND KEY MEDICINES TO MILLIONS OF PATIENTS IN NEED

A4ONE is launching and scaling the platform, with opportunities for partners/donors to participate in creating commercially affordable sustainable solutions that have long term impact, for access to medicines.